February 2019

ONCOLOGY

MEN WITH AGRESSIVE PROSTATE CANCER MAY GET NEW POWERFUL DRUG OPTION

Featuring: Maha Hussain, MD

Episode Summary

Maha Hussain, MD, FACP, FASCO, deputy director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses this designation, that the latest advances in medicational the management of prostate cancer and how her work, that was recently published in the New England Journal of Medicine, will benefit men with aggressive states of prostate cancer.

This article was originally published in the Feinberg School of Medicine News Center on February 18, 2019.
Maha Hussain, MD, FACP, FASCO, is the Genevieve Teuton Professor of Medicine in the Division of Hematology Oncology, Department of Medicine, and the Deputy Director at the Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like